Sp1-decoy oligodeoxynucleotide inhibits high glucose-induced mesangial cell proliferation
- PMID: 15178441
- DOI: 10.1016/j.bbrc.2004.05.025
Sp1-decoy oligodeoxynucleotide inhibits high glucose-induced mesangial cell proliferation
Abstract
Mesangial expansion caused by cell proliferation and glomerular extracellular matrix accumulation is one of the earliest renal abnormalities observed at the onset of hyperglycemia in diabetes mellitus. Transcription factor Sp1 is implicated in the transcriptional regulation of a wide range of genes participating in cell proliferation, and is assumed to play an essential role in mesangial expansion. We have generated a phosphorothioated double-stranded Sp1-decoy oligodeoxynucleotide that effectively blocks Sp1 binding to the promoter region for transcriptional regulation of transforming growth factor-beta1 and plasminogen activator inhibitor-1. The Sp1-decoy oligodeoxynucleotide suppressed transcription of these cytokines and proliferation of primary rat mesangial cells in response to high glucose. These results suggest that the Sp1-decoy oligodeoxynucleotide could be a powerful tool in preventing the pathogenesis of renal hypertrophy.
Similar articles
-
Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo.Gene Ther. 2004 Jun;11(11):916-23. doi: 10.1038/sj.gt.3302236. Gene Ther. 2004. PMID: 14961072
-
Suppression of mesangial cell proliferation and extracellular matrix production in streptozotocin-induced diabetic rats by Sp1 decoy oligodeoxynucleotide in vitro and in vivo.J Cell Biochem. 2008 Feb 1;103(2):663-74. doi: 10.1002/jcb.21440. J Cell Biochem. 2008. PMID: 17557290
-
Antifibrotic effect through the regulation of transcription factor using ring type-Sp1 decoy oligodeoxynucleotide in carbon tetrachloride-induced liver fibrosis.J Gene Med. 2009 Sep;11(9):824-33. doi: 10.1002/jgm.1355. J Gene Med. 2009. PMID: 19554625
-
Mesangial cell-predominant functional gene, megsin.Clin Exp Nephrol. 2003 Jun;7(2):87-92. doi: 10.1007/s10157-003-0228-0. Clin Exp Nephrol. 2003. PMID: 14586725 Review.
-
The pathobiology of the mesangium.Kidney Int. 1992 Mar;41(3):524-9. doi: 10.1038/ki.1992.74. Kidney Int. 1992. PMID: 1573822 Review. No abstract available.
Cited by
-
Small-nucleic-acid-based therapeutic strategy targeting the transcription factors regulating the vascular inflammation, remodeling and fibrosis in atherosclerosis.Int J Mol Sci. 2015 May 22;16(5):11804-33. doi: 10.3390/ijms160511804. Int J Mol Sci. 2015. PMID: 26006249 Free PMC article. Review.
-
High Glucose Up-regulates ADAM17 through HIF-1α in Mesangial Cells.J Biol Chem. 2015 Aug 28;290(35):21603-14. doi: 10.1074/jbc.M115.651604. Epub 2015 Jul 14. J Biol Chem. 2015. PMID: 26175156 Free PMC article.
-
Cilostazol ameliorates diabetic nephropathy by inhibiting highglucose- induced apoptosis.Korean J Physiol Pharmacol. 2020 Sep 1;24(5):403-412. doi: 10.4196/kjpp.2020.24.5.403. Korean J Physiol Pharmacol. 2020. PMID: 32830147 Free PMC article.
-
Targeted blockage of signal transducer and activator of transcription 5 signaling pathway with decoy oligodeoxynucleotides suppresses leukemic K562 cell growth.DNA Cell Biol. 2011 Feb;30(2):71-8. doi: 10.1089/dna.2010.1112. Epub 2010 Nov 22. DNA Cell Biol. 2011. PMID: 21091189 Free PMC article.
-
Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells.Am J Physiol Renal Physiol. 2015 Aug 1;309(3):F204-15. doi: 10.1152/ajprenal.00150.2015. Epub 2015 Jun 3. Am J Physiol Renal Physiol. 2015. PMID: 26041445 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources